Funder: National Institutes of Health
Due Dates (Anticipated): February 2027 (anticipated)
Funding Amounts: Not specified; award ceiling/floor not listed. See program page for updates.
Summary: Supports research and preclinical development of next-generation malaria vaccines, leveraging novel approaches and technologies.
Key Information: This is a forecasted opportunity; details may change—monitor the program page for updates.